Micelle-Associated Protein in Epoetin Formulations: A Risk Factor for Immunogenicity?

Suzanne Hermeling, Huub Schellekens, Daan J. A. Crommelin, Wim Jiskoot
  • Pharmaceutical Research, December 2003, Springer Science + Business Media
  • DOI: 10.1023/b:pham.0000008034.61317.02

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1023/b:pham.0000008034.61317.02

The following have contributed to this page: Wim Jiskoot

In partnership with: